Intracranial electrode stimulation is a therapeutic technique used in the treatment of epilepsy, or seizure disorders. This form of treatment involves surgically implanting electrodes into the brain, which can detect and moderate abnormal electrical signals in patients with epilepsy. During this procedure, thin, flexible wires with electrodes at their tips are inserted into the brain. The electrodes may be placed in the gray matter, the white matter, or both. Once implanted, the electrodes are connected to an electric stimulator, which can detect electrical activity associated with abnormal brain signals. When the electrodes detect these signals, the stimulator will produce a low-voltage electric current to suppress them. This suppresses seizures or reduces their severity. In some cases, the implanted electrodes can also be used to map the brain’s electrical activity, helping to explain why an area of the brain is involved in seizure activity. By promoting detailed understanding of the structures and the pathways in the brain that are associated with seizures, intracranial electrode stimulation can lead to more targeted and successful treatment. Intracranial electrode stimulation is generally considered to be a safe and effective treatment for various types of epilepsy. The procedure has been endorsed by the American Epilepsy Society and is generally well tolerated by patients. Following implantation, patients’ quality of life has been shown to improve and their seizure frequency has significantly decreased, greatly improving their outlook in life. Overall, implanting electrodes into the brain to detect and moderate abnormal electrical signals is a safe and highly effective means of treating epileptic seizures. The successful use of intracranial electrode stimulation has improved the lives of many patients suffering from seizures or seizure disorders.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom